XOMA Royalty (XOMA) Net Margin Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) Net Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
-2,293.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-2,293.00 |
| Dec 31, 2025 |
-201,744.00 |
| Sep 30, 2025 |
7.52 Mn |
| Jun 30, 2025 |
29,548.00 |
| Mar 31, 2025 |
76,756.00 |
| Dec 31, 2024 |
304,451.00 |
| Sep 30, 2024 |
-6.83 Mn |
| Jun 30, 2024 |
59,756.00 |
| Mar 31, 2024 |
161,884.00 |
| Dec 31, 2023 |
-66,961.00 |
| Sep 30, 2023 |
27,217.00 |
| Jun 30, 2023 |
-38,090.00 |
| Mar 31, 2023 |
-226,077.00 |
| Dec 31, 2022 |
-1.53 Mn |
| Sep 30, 2022 |
-49,749.00 |
| Jun 30, 2022 |
-23,666.00 |
| Mar 31, 2022 |
189,967.00 |
| Dec 31, 2021 |
1.48 Mn |
| Sep 30, 2021 |
-28,323.00 |
| Jun 30, 2021 |
55,330.00 |
